PlasmaTech Biopharmaceuticals (Nasdaq: PTBI) caught the eye of momentum traders Tuesday, a day after Soros Fund Management ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE